Evidence map›Paper›PMID 42139696›Full record

ArticleJMIR human factors2026

Development, Implementation, and Preliminary Results of a Novel Social Network for Rare Disease Communities: Mixed Methods Study.

Lara Fendrich, Henriette Högl, Ralf Schmidt, David Bascom, Armin Berger, Max Lübbering, Gundula Ernst, Justus Schumacher, Sabrina Hölzer, Lorenz Grigull

Abstract read
In one paragraph

Article in JMIR human factors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lara FendrichCenter for Rare Diseases, University Hospital Bonn, Venusberg-Campus 1, Geb. 13 (BMZ), Bonn, 53127, Germany, 49 228 287 51472.ORCID 0000-0002-8063-0373
Henriette HöglKindernetzwerk e.V, Aschaffenburg, Germany.ORCID 0009-0004-9542-4937
Ralf SchmidtdigitalUX, Uplengen, Germany.ORCID 0009-0004-9753-3731
David Bascom99 Grad, Wiesbaden, Germany.ORCID 0009-0007-9060-691X
Armin BergerFraunhofer Institute for Intelligent Analysis and Information Systems, Bonn, Germany.ORCID 0009-0003-1924-8401
Max LübberingFraunhofer Institute for Intelligent Analysis and Information Systems, Bonn, Germany.ORCID 0000-0001-6291-9459
Gundula ErnstHannover Medical School, Hanover, Germany.ORCID 0000-0002-2483-7206
Justus SchumacherCenter for Rare Diseases, University Hospital Bonn, Venusberg-Campus 1, Geb. 13 (BMZ), Bonn, 53127, Germany, 49 228 287 51472.ORCID 0009-0000-2968-8265
Sabrina HölzerErnst Abbe University of Applied Sciences Jena, Jena, Germany.ORCID 0009-0003-5441-2756
Lorenz GrigullCenter for Rare Diseases, University Hospital Bonn, Venusberg-Campus 1, Geb. 13 (BMZ), Bonn, 53127, Germany, 49 228 287 51472.ORCID 0000-0001-8807-2874

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rare diseases affect approximately 20 million Europeans, presenting unique challenges such as delayed diagnoses, limited therapies, and significant personal and financial burden. While resilience-supporting factors such as peer support are available and artificial intelligence-based diagnostic tools are being developed further, there is a lack of a dedicated online social network connecting patients, caregivers, relatives, and experts. This study presents the development and preliminary findings of Unrare.me, a novel social network designed to provide a secure space for experts and individuals affected by rare and chronic diseases (diagnosed and undiagnosed). Objective: This study aimed to design, develop, and evaluate a social networking platform tailored to the needs of different stakeholders of the rare disease community, facilitating interaction, knowledge exchange, and emotional support while prioritizing data security. Methods: This multidisciplinary, multicenter initiative brought together patient groups, health care professionals, psychologists, and web design experts. A literature review assessed existing networking approaches in the rare disease community. Structured interviews and user journey mapping defined user needs and essential app features. Iterative prototyping and stakeholder discussions informed the final design, which was developed into a functional app launched in December 2023 on major platforms. A survey conducted four months post-launch evaluated user feedback. Data security was prioritized throughout development. Results: A total of 270 users (approximately 1 in 7 users at the time) participated in the evaluation. Most of them (n=221, 81.9%) registered to connect with others in similar situations, whereas 56.7% (n=153) sought expert input and 44.4% (n=120) looked for disease-related information. The app received positive ratings for usability (mean 6.12, SD 1.03; out of 7), accessibility (mean 5.59, SD 1.22), and design (mean 5.84, SD 1.12), as well as overall impression (mean grade of 2.24, SD 0.90 on a scale from 1-6, with 1 being the best score). Data security was highly rated (mean 5.58, SD 1.15). The app's ontology was suitable for 77% (n=208) of the participants, enabling them to find their diagnosis, and 60.7% (n=164) of users found at least one match. Matching preferences centered on shared diagnosis (mean 82.5, SD 25.1 on a visual analog scale from 0 to 100), symptoms (mean 74.2, SD 25.8), and everyday experiences (mean 69.6, SD 29.5). Overall, users welcomed the opportunity to network with each other securely and highlighted areas for further improvement, such as enhanced matching features and group chat options. Conclusions: Unrare.me has generated significant interest and engagement within the German rare disease community, serving as a valuable tool for peer support, knowledge sharing, and expert identification. Current challenges include optimizing user acquisition and refining matching algorithms. Planned features include group chats, expert interaction, and gamification elements. Unrare.me illustrates the potential of tailored digital solutions to address unmet needs in the rare disease community.

Indexed as

Mobile ApplicationsOnline Social NetworkingRare DiseasesSocial NetworkingSocial SupportHumansAIappartificial intelligencemutual supportrare diseasesocial network

Identifiers

PMID42139696
PMCPMC13179036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.